Results 301 to 310 of about 95,391 (321)

Drug-Eluting Coronary Stents

Current Problems in Cardiology, 2006
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty.
David R. Holmes, Jassim Al Suwaidi, Amar M Salam   +2 more
openaire   +3 more sources

Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside.

Cardiovascular Research, 2022
J. Nicolas, C. Pivato, M. Chiarito, F. Beerkens, D. Cao, R. Mehran   +5 more
semanticscholar   +1 more source

Update on Drug-Eluting Stents

Dimensions of Critical Care Nursing, 2007
Coronary artery disease is the number 1 killer of Americans. There are many efforts underway to prevent and treat this life-threatening disease. One such treatment is the placement of drug-eluting stents. However, recent reports that show an increased risk of potentially life-threatening complications associated with drug-eluting stents have surfaced ...
openaire   +3 more sources

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

Journal of the American Medical Association (JAMA), 2005
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. Sangiorgi, G. Stanković, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, A. Colombo   +15 more
semanticscholar   +1 more source

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

The Lancet, 2013
R. Byrne, F. Neumann, J. Mehilli, S. Pinieck, Britta Wolff, K. Tiroch, S. Schulz, M. Fusaro, I. Ott, T. Ibrahim, J. Hausleiter, C. Valina, J. Pache, K. Laugwitz, S. Massberg, A. Kastrati   +15 more
semanticscholar   +1 more source

Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.

EuroIntervention, 2014
T. Adriaenssens, J. Dens, G. Ughi, J. Bennett, C. Dubois, P. Sinnaeve, S. Wiyono, M. Coosemans, A. Belmans, J. D’hooge, M. Vrolix, W. Desmet   +11 more
semanticscholar   +1 more source

Drug-Eluting Stents Are Safe

Clinical Pharmacology & Therapeutics, 2009
Scot Garg, Patrick W. Serruys
openaire   +4 more sources

Contemporary coronary drug-eluting and coated stents: a mini-review

Cardiovascular Intervention and Therapeutics, 2020
Y. Saito, Yoshio Kobayashi
semanticscholar   +1 more source

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

The Lancet, 2018
O. Varenne, S. Cook, G. Sideris, S. Kedev, T. Cuisset, D. Carrié, T. Hovasse, P. Garot, R. Mahmoud, C. Spaulding, G. Helft, J. F. Fernández, S. Brugaletta, E. Pinar-Bermúdez, J. Ferré, P. Commeau, E. Teiger, K. Bogaerts, M. Sabaté, M. Morice, P. Sinnaeve   +20 more
semanticscholar   +1 more source

Long‐term efficacy of drug coated balloons compared with new generation drug‐eluting stents for the treatment of de novo coronary artery lesions

Catheterization and cardiovascular interventions, 2018
D. Venetsanos, S. Lawesson, Georgios Panayi, T. Tödt, U. Berglund, E. Swahn, J. Alfredsson   +6 more
semanticscholar   +1 more source